Literature DB >> 20382598

Hilar inflammatory pseudotumor mimicking hilar cholangiocarcinoma.

Fei-Tao Deng1, Yan-Xu Li, Lun Ye, Ling Tong, Xiu-Ping Yang, Xin-Qun Chai.   

Abstract

BACKGROUND: Inflammatory pseudotumor of the biliary tract is a benign disease, and is extremely rare. Its diagnosis often depends on pathological examination after operation. The histopathological examination shows inflammatory lesions with a polymorphous infiltration and variable amounts of fibrous tissue. This study was undertaken to elucidate that an inflammatory pseudotumor in the right hepatic duct is especially difficult to distinguish from hilar cholangiocarcinoma.
METHOD: The clinical data of one patient with inflammatory pseudotumor of the right hepatic duct were analyzed.
RESULTS: An occupying lesion of the right hepatic duct was revealed by abdominal ultrasound and magnetic resonance cholangiopancreatography. The right hepatic duct inflammatory pseudotumor was not identified during the operation but was confirmed by postoperative histopathological analysis. The patient recovered well without any serious complication.
CONCLUSIONS: The preoperative evaluation for optimizing surgical management is important to the diagnosis of hepatobiliary occupying lesions. The evaluation involves clinical manifestations, imaging appearance and tumor markers. Malignant tumors and possible benign lesions should be considered to avoid aggressive surgical treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20382598

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  6 in total

1.  Hilar Inflammatory Pseudotumour with Hepatic Artery Atheroma- mimicker of Klatskin Tumour.

Authors:  Archana Rastogi; Chhagan Bihari; Nalini Gupta; Pranjal Deka; Arvind Kumar; Sanjay Singh Negi; Ankur Arora
Journal:  Indian J Surg Oncol       Date:  2014-05-27

2.  Inflammatory myofibroblastic tumour of liver masquerading as hilar cholangiocarcinoma.

Authors:  R Subash; Ml Arunkumar; Va Iyoob; N Bonny
Journal:  J Surg Case Rep       Date:  2011-08-01

3.  Serum NGAL to Clinically Distinguish Cholangiocarcinoma from Benign Biliary Tract Diseases.

Authors:  Kawin Leelawat; Siriluck Narong; Jerasak Wannaprasert; Surang Leelawat
Journal:  Int J Hepatol       Date:  2010-08-31

4.  Precise recognition of liver inflammatory pseudotumor may prevent an unnecessary surgery.

Authors:  Amir Hossein Sarrami; Mohammad Mehdi Baradaran-Mahdavi; Mohsen Meidani
Journal:  Int J Prev Med       Date:  2012-06

Review 5.  Inflammatory Myofibroblastic Tumor of the Liver: A Diagnostic Challenge.

Authors:  Gülsüm Özlem Elpek
Journal:  J Clin Transl Hepatol       Date:  2014-03-15

6.  Novel Serum Biomarkers to Differentiate Cholangiocarcinoma from Benign Biliary Tract Diseases Using a Proteomic Approach.

Authors:  Tavan Janvilisri; Kawin Leelawat; Sittiruk Roytrakul; Atchara Paemanee; Rutaiwan Tohtong
Journal:  Dis Markers       Date:  2015-04-28       Impact factor: 3.434

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.